Business & Economics
Emerging multinationals
100%
Market Entry
72%
Pharmaceuticals
55%
Incumbents
27%
United States of America
26%
Foreign Market Entry Strategy
18%
Generic Drugs
14%
Entry Strategy
14%
Long Period
10%
Exporting
10%
Multinationals
9%
Drugs
9%
Competitors
8%
R and D
7%
Developing Countries
6%
Assets
6%
Social Sciences
opening up of markets
93%
pharmaceutical
61%
drug
15%
market
12%
acquisition
12%
sales
10%
assets
9%
firm
8%
developing country
8%
present
6%
time
3%
Agriculture & Biology
markets
45%
drugs
44%
foreign markets
17%
drug formulations
15%
assets
13%
developing countries
10%
sales
10%
Earth & Environmental Sciences
drug
53%
market
47%
firm
9%
developing world
8%